Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Immune Design Corp. (IMDZ)

4.4715 -0.279 (-5.86%)

06-21 12:06

Open:

4.75

Pre. Close:

4.75

High:

4.75

Low:

4.45

Volume:

79,545

Market Cap:

215M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.806 - 4.826

4.826 - 4.844

Low:

4.553 - 4.574

4.574 - 4.594

Close:

4.716 - 4.749

4.749 - 4.781

Technical analysis  (as of: 2018-06-21 11:49:59 AM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 5.72     One year: 6.68

Support:

Support1: 4.37    Support2: 4.05

Resistance:

Resistance1: 4.90    Resistance2: 5.72

Pivot:

4.44

Moving Averages:

MA(5): 4.63     MA(20): 4.42

MA(100): 3.73     MA(250): 5.82

MACD:

MACD(12,26): 0.15     Signal(12,26,9): 0.15

%K %D:

%K(14,3): 64.67     %D(3): 68.43

RSI:

RSI(14): 55.86

52-Week:

High: 13.05  Low: 2.8  Change(%): -53.3

Average Vol(K):

3-Month: 26470  10-Days 22255

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
IMDZ has closed below upper band by 40.5%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-06-18T01:15:42-04:00
Week 25 Breakout Forecast: Short-Term Picks To Give You An Edge

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

48.13

Shares Float (M)

47.67

% Held by Insiders

% Held by Institutions

32.40

Shares Short (K)

1737

Shares Short Prior Month (K)

1910

Stock Financials

EPS

-1.630

EPS Est. Current Year

-2.290

EPS Est. Next Year

-2.320

EPS Est. Next Quarter

-0.620

Forward EPS

-1.288

Book Value (p.s.)

1.680

PEG Ratio

-0.71

Profit Margin

Operating Margin

-2412.76

Return on Assets (ttm)

-41.9

Return on Equity (ttm)

-46.2

Qtrly Rev. Growth

-90.8

Gross Profit (p.s.)

0.025

Sales Per Share

EBITDA (p.s.)

-0.572

Qtrly Earnings Growth

Operating Cash Flow (M)

-58.26

Levered Free Cash Flow (M)

-27.41

atoplab.com

Valuation

P/E

-2.76

P/E Growth Ratio

-0.05

P/BV

2.68

P/S

3613009920.00

P/CF

-3.72

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.